Evidence map›Paper›PMID 39738092›Full record

ArticleNPJ biofilms and microbiomes2024

The impact of antioxidant-ciprofloxacin combinations on the evolution of antibiotic resistance in Pseudomonas aeruginosa biofilms.

Doaa Higazy, Marwa N Ahmed, Oana Ciofu

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Evolutionary adaptations ofMicrobiology spectrum · 2026
    Article
  4. Article
  5. Review
  6. Mapping the knowledge landscape ofFrontiers in cellular and infection microbiology · 2026
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Doaa HigazyCosterton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, 2200, Denmark.
Marwa N AhmedDepartment of Microbiology, Faculty of Agriculture, Cairo University, Giza, 12613, Egypt.
Oana CiofuCosterton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, 2200, Denmark. ociofu@sund.ku.dk.ORCID http://orcid.org/0000-0001-5648-4858

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolution of antimicrobial resistance (AMR) in biofilms, driven by mechanisms like oxidative stress, is a major challenge. This study investigates whether antioxidants (AOs) such as N-acetyl-cysteine (NAC) and Edaravone (ED) can reduce AMR in Pseudomonas aeruginosa biofilms exposed to sub-inhibitory concentrations of ciprofloxacin (CIP). In vitro experimental evolution studies were conducted using flow cells and glass beads biofilm models. Results showed that combining CIP with antioxidants (CIP-AOs) effectively reduced the development of CIP resistance. Isolates from biofilms treated with CIP-AO had significantly lower minimum inhibitory concentrations (MICs) of CIP compared to those treated with CIP alone. Whole-genome sequencing (WGS) revealed mutations in the negative regulators of efflux pumps, nfxB, and nalC, in CIP-only treated biofilm populations. The occurrence of nfxB mutations was significantly lower in flow cell biofilms treated with CIP-AO compared to CIP alone. These findings suggest that antioxidants could play a role in mitigating AMR development in biofilms.

Indexed as

Anti-Bacterial AgentsAntioxidantsBiofilmsCiprofloxacinDrug Resistance, BacterialMicrobial Sensitivity TestsMutationPseudomonas aeruginosaAcetylcysteineBacterial ProteinsDNA-Binding ProteinsOxidative StressTranscription FactorsWhole Genome SequencingAcetylcysteineAnti-Bacterial AgentsAntioxidantsBacterial ProteinsCiprofloxacinDNA-Binding ProteinsNfxB protein, Pseudomonas aeruginosaTranscription Factors

Identifiers

PMID39738092
PMCPMC11685532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.